It has also been found that transgenic mice over expressing IL-10 under the control of IL-2 promoter were unable to restrict the progression of immunogenic tumor whereas applying anti IL-10 mAbs in these mice restored the in vivo antitumor response [40]. This evidence concerns the gene IL2 and neoplasm.